HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rogaine Extra Strength launch to be supported with $80 mil.; ads break Jan. 1.

This article was originally published in The Rose Sheet

Executive Summary

ROGAINE EXTRA STRENGTH $80 MIL. AD/PROMO BUDGET TO SUPPORT LAUNCH of the 5% minoxidil solution in its first 12 months on the market. Pharmacia & Upjohn received FDA approval Nov. 14 for the baldness treatment, a stronger version of its 2% minoxidil solution. The $80 mil. ad/promo budget represents an increase over spending for the launch of the original product as an over-the-counter drug in 1996.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel